Improving well-being for individuals living with a blood disorder through evidence-based programs.
ID: 355856Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCBDDD (HHS-CDC-NCBDDD)

Award Range

$135K - $450K

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355856
Timeline
    Description

    The Centers for Disease Control - NCBDDD is offering a federal grant opportunity aimed at improving the well-being of individuals living with blood disorders through evidence-based programs. The initiative seeks to enhance the emotional, social, and physical health of affected individuals by promoting mental health literacy and adapting programs that build psychosocial skills, ultimately aiming to reduce morbidity and improve quality of life. With an estimated total program funding of $5,925,000, the agency plans to award four cooperative agreements, with individual awards ranging from $135,000 to $450,000. Interested applicants must apply by May 15, 2025, and can reach out to Dr. Fiona Bethea at gvu0@cdc.gov or by phone at 404-639-4033 for further information.

    Point(s) of Contact
    Fiona Bethea, PhD, MPH
    (404) 639-4033
    gvu0@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.
    Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan." This initiative aims to gather unique data to enhance understanding of the resources and opportunities necessary to improve outcomes for individuals with autism and Fragile X Syndrome (FXS) throughout their lives. The program consists of three components: data collection on autistic teens and young adults, data collection on individuals with FXS, and dissemination of public health products to support these populations. The total estimated funding for this program is $18 million, with 11 awards expected to be made. Interested applicants can reach out to Seema Gupta at (770) 488-6527 or via email at cvk9@cdc.gov for further information. Applications must be submitted electronically by January 30, 2026, with the project anticipated to start on July 1, 2026.
    Comprehensive Suicide Prevention Program for States
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Comprehensive Suicide Prevention Program for States," aimed at implementing and evaluating a comprehensive approach to suicide prevention, particularly for disproportionately affected populations such as veterans, rural communities, and LGBTQ individuals. Eligible applicants must submit proposals with a funding request between $650,000 and $1,200,000, including various letters of commitment and support, as well as a preliminary organizational chart detailing required staff roles. The total estimated program funding is approximately $49.7 million, with an expected 42 awards to be made, and applications must be submitted electronically by 11:59 PM ET on March 3, 2026, with the anticipated award date set for June 19, 2026. For further inquiries, applicants can contact the Comprehensive Suicide Prevention mailbox at csp@cdc.gov.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Increasing awareness and knowledge of Alpha-gal Syndrome in the United States." The primary objective of this funding opportunity is to enhance awareness, surveillance, and patient care related to Alpha-gal Syndrome (AGS), an emerging health condition that is not nationally notifiable. The grant seeks to support the formation of a professional association to disseminate knowledge about AGS, create educational resources for both the public and healthcare providers, and conduct enhanced public health surveillance, with a total estimated program funding of $10 million and awards ranging from $25,000 to $1 million. Interested applicants, including bona fide agents, must submit their applications electronically by May 1, 2026, with an anticipated award date of July 1, 2026. For further inquiries, applicants can contact Jeff Borchert at gqx1@cdc.gov or by phone at (970) 221-6494.
    Centers of Excellence in Healthcare Quality: Detecting and Responding to Threats to Healthcare Safety
    Centers for Disease Control - NCEZID
    The Centers for Disease Control - NCEZID is offering a federal grant opportunity titled "Centers of Excellence in Healthcare Quality: Detecting and Responding to Threats to Healthcare Safety." This initiative aims to establish a collaborative network among healthcare systems, facilities, and public health partners to enhance the detection, response, and prevention of threats to patient and healthcare worker safety, ultimately improving the quality and resilience of U.S. healthcare delivery. The program is particularly relevant for various healthcare settings, including hospitals, nursing homes, and outpatient facilities, and encourages partnerships with public health departments and relevant entities. Interested applicants can apply for funding ranging from $2.5 million to $15 million, with an estimated total program funding of $750 million and an expected ten awards. Applications must be submitted electronically by June 5, 2026, with the anticipated award date set for August 1, 2026. For further inquiries, applicants may contact Carla Doan at gon5@cdc.gov or by phone at 770-488-8354.
    Research Grants for Preventing Violence and Violence Related Injury (R01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering research grants aimed at preventing violence and violence-related injuries through the initiative titled "Research Grants for Preventing Violence and Violence Related Injury (R01)." This program seeks to fund effectiveness research that evaluates innovative programs, practices, or policies designed to address interpersonal violence and suicide, particularly among youth and young adults aged 10 to 24 years. With an estimated total program funding of $9.6 million, the CDC anticipates awarding approximately eight grants, with individual awards ranging from $0 to $400,000. Interested applicants can reach out to Samantha Case at ncipcerpo@cdc.gov or by phone at 907-271-1569, with applications due by December 1, 2025, and project start dates expected around September 30, 2026.
    Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity for the continuation and expansion of the National Mesothelioma Virtual Bank for Translational Research (U24). This cooperative agreement aims to enhance the collection of biospecimens and related data to support biomedical research on malignant mesothelioma, requiring applicants to have an established registry and tissue bank capable of functioning as a national resource. The initiative is crucial for advancing research into early disease markers, treatment modalities, and improving health outcomes for mesothelioma patients. The total estimated funding for this program is $5.5 million, with a ceiling and floor award amount of $1.1 million, and applications must be submitted electronically by March 23, 2026, with an anticipated award date of August 1, 2026. For further inquiries, interested parties can contact Bridgette Garrett at bgarrett@cdc.gov or by phone at 770-488-5715.
    Promoting World Trade Center Health Program Youth Research Cohort Recruitment and Retention Using Principles of Community Engaged Research (CEnR) to Build Community Participation (U01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Promoting World Trade Center Health Program Youth Research Cohort Recruitment and Retention project, aimed at enhancing community engagement through Community Engaged Research (CEnR) principles. The initiative seeks to establish authentic partnerships between communities and health researchers to effectively recruit and retain participants, particularly young survivors and advocacy organizations, while evaluating the effectiveness of pilot studies throughout the process. This funding opportunity, categorized as a discretionary federal grant, offers a total estimated program funding of $24 million, with individual awards ranging from $0 to $1 million, and is expected to support approximately six projects. Interested applicants can reach out to Eduardo O'Neill, PhD, at 404-718-8844 or via email at fzt4@cdc.gov for further information, with applications due by 5:00 PM local time on February 12, 2026.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    Cooperative Centers of Excellence in Hematology (CCEHs)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Cooperative Centers of Excellence in Hematology (CCEHs)" aimed at enhancing the nonmalignant hematology research community through a national network of resources and services. This program seeks to provide state-of-the-art expertise, enrichment activities, and small pilot funding to improve the quality and transparency of hematology research. With an estimated total program funding of $3,745,000 and the expectation of awarding five grants, interested applicants can reach out to Jennifer Norton at jenna.norton@nih.gov or by phone at 301-402-5496 for further details. The application process is set to begin with a synopsis posting on April 1, 2026, and will close on July 10, 2026, with awards anticipated by January 30, 2027.